Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company, has announced that it will report its third quarter fiscal year 2024 financial results after the market closes on Tuesday, November 12th, 2024. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the quarterly results and provide a corporate update, followed by a question and answer session.
Interested parties can access the live webcast through the company's website at investors.organogenesis.com or via a provided link. A teleconference option is also available. The webcast will be archived on the company's website for approximately one year after the event.
Organogenesis Holdings Inc. (Nasdaq: ORGO), una delle principali aziende di medicina rigenerativa, ha annunciato che riporterà i suoi risultati finanziari per il terzo trimestre dell'anno fiscale 2024 dopo la chiusura del mercato il martedì 12 novembre 2024. L'azienda ospiterà una teleconferenza alle 17:00 ora orientale dello stesso giorno per discutere i risultati trimestrali e fornire un aggiornamento aziendale, seguita da una sessione di domande e risposte.
Le parti interessate possono accedere alla diretta web tramite il sito web della compagnia all'indirizzo investors.organogenesis.com o tramite un link fornito. È inoltre disponibile un'opzione di teleconferenza. La diretta sarà archiviata sul sito web della compagnia per circa un anno dopo l'evento.
Organogenesis Holdings Inc. (Nasdaq: ORGO), una empresa líder en medicina regenerativa, ha anunciado que reportará sus resultados financieros del tercer trimestre del año fiscal 2024 después del cierre del mercado el martes 12 de noviembre de 2024. La compañía llevará a cabo una conferencia telefónica a las 5:00 p.m. hora del este el mismo día para discutir los resultados trimestrales y proporcionar una actualización corporativa, seguida de una sesión de preguntas y respuestas.
Las partes interesadas pueden acceder a la transmisión en vivo a través del sitio web de la empresa en investors.organogenesis.com o a través de un enlace proporcionado. También hay disponible una opción de teleconferencia. La transmisión se archivará en el sitio web de la empresa por aproximadamente un año después del evento.
Organogenesis Holdings Inc. (Nasdaq: ORGO), 선도적인 재생 의료 회사,가 2024 회계년도 3분기 재무 결과를 2024년 11월 12일 화요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 5:00에 분기 결과를 논의하고 기업 업데이트를 제공하기 위한 콘퍼런스 콜을 개최하며, 이후 질의응답 세션이 이어집니다.
관심이 있는 분들은 회사 웹사이트 investors.organogenesis.com를 통해 실시간 웹캐스트에 접속하거나 제공된 링크를 통해 접속할 수 있습니다. 전화 회의 옵션도 제공됩니다. 웹캐스트는 이벤트 이후 약 1년 동안 회사 웹사이트에 보관됩니다.
Organogenesis Holdings Inc. (Nasdaq: ORGO), une entreprise leader dans le domaine de la médecine régénérative, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre de l'exercice 2024 après la fermeture des marchés le mardi 12 novembre 2024. L'entreprise organisera une conférence téléphonique à 17h00, heure de l'Est le même jour pour discuter des résultats trimestriels et fournir une mise à jour de l'entreprise, suivie d'une session de questions et réponses.
Les personnes intéressées peuvent accéder à la diffusion en direct via le site Web de l'entreprise à l'adresse investors.organogenesis.com ou via un lien fourni. Une option de téléconférence est également disponible. La diffusion sera archivée sur le site Web de l'entreprise pendant environ un an après l'événement.
Organogenesis Holdings Inc. (Nasdaq: ORGO), ein führendes Unternehmen im Bereich der regenerativen Medizin, hat bekannt gegeben, dass es seine finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2024 nach Marktschluss am Dienstag, den 12. November 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Konferenzschaltung abhalten, um die Quartalsergebnisse zu besprechen und ein Unternehmensupdate zu geben, gefolgt von einer Frage- und Antwortsitzung.
Interessierte Parteien können über die Website des Unternehmens unter investors.organogenesis.com oder über einen bereitgestellten Link auf den Live-Webcast zugreifen. Es steht auch eine Telefonkonferenz-Option zur Verfügung. Der Webcast wird etwa ein Jahr nach der Veranstaltung auf der Website des Unternehmens archiviert.
- None.
- None.
CANTON, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that third quarter of fiscal year 2024 financial results will be reported after the market closes on Tuesday, November 12th.
Management will host a conference call at 5:00 p.m. Eastern Time on November 12th to discuss the results of the quarter and provide a corporate update with a question and answer session. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.organogenesis.com. The webcast will be archived on the company website for approximately one year.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.
FAQ
When will Organogenesis Holdings (ORGO) report its Q3 2024 financial results?
What time is the Organogenesis Holdings (ORGO) Q3 2024 earnings call scheduled for?
How can investors access Organogenesis Holdings' (ORGO) Q3 2024 earnings call?
How long will the webcast of Organogenesis Holdings' (ORGO) Q3 2024 earnings call be available?
